Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy-Reference-Cited by-同舟云学术

Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy

Published:2002-01-30 Issue:1 Volume:2 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Tsavaris Nicolas,Kosmas Christos,Vadiaka Maria,Koufos Christos

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-2-2.pdf

Reference14 articles.

1. Pinedo HM, Peters GF: Fluorouracil: biochemistry and pharmacology. J Clin Oncol. 1988, 6: 1653-1664.

2. Cunningham D, Zalcberg J, Smith I, Gore M, Pazdur R, Burris H, Merpol NJ, Kennealy G, Seymour L, the "Tomudex" International Study Group: "Tomudex" (2D1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. Ann Oncol. 1996, 7: 179-182.

3. Cunnningham D, Zalcberg JR, Rath U, Oliver I, Van Cutsem E, Svensson C, Seitz JF, Harper P, Kerr D, Perez-Manga G: Final results of a randomized trial comparing "Tomudex" (raltitrexed) with 5-Fluorouracil plus leucovorin in advanced colorectal cancer. Ann Oncol. 1996, 7: 961-965.

4. Cunningham D, Pyrhonen S, James RD, Punt CJA, Hickish TF, Heikkila R, Johannesen TB, Starkhammar H, Tophan CA, Award L, et al: Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet. 1998, 352: 1413-1418. 10.1016/S0140-6736(98)02309-5.

5. Rougier P, Van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca R, Navarro M, Morant R, Bleiberg H, Wils J, et al: Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet. 1998, 352: 1407-1412. 10.1016/S0140-6736(98)03085-2.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted and Therapeutic Efficacy of 5-Fluorouracil-Loaded Polylactic Acid Nanocomplexes in Gastric Cancer;Journal of Biomedical Nanotechnology;2024-08-01

2. Use of a Carbon Nanoparticle Tracer to Detect Sentinel Lymph Nodes for the Precise Treatment of Endometrial Carcinoma;Journal of Biomedical Nanotechnology;2022-11-01

3. Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer;Clinical Colorectal Cancer;2021-06

4. Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids;Cancer Biology and Medicine;2021

5. Exposure‐response analysis of Raltitrexed assessing liver toxicity;British Journal of Clinical Pharmacology;2020-09-04